Core Viewpoint - Beijing Tongrentang Group has initiated a strict brand management action in response to issues related to product quality and unauthorized use of its brand name, particularly concerning the "Tongrentang Antarctic Krill Oil" incident, which revealed a phospholipid content of zero in the product [2][6]. Group 1: Brand Management Actions - The company has launched a comprehensive investigation into the misconduct of involved parties and has initiated a special action to manage its brand strictly [4]. - As of December 24, the company has conducted over 520 inspections of its affiliated units/stores and filed nearly 600 complaints against infringing products on major e-commerce platforms [5]. - The company has also identified and reported over 120 unauthorized stores using the Tongrentang name, aiming to combat improper use of its trademark [5]. Group 2: Regulatory Response - The State Administration for Market Regulation plans to enhance supervision of food production entrusted to third parties, addressing issues highlighted by the Antarctic krill oil incident [6]. - A new regulatory framework, the "Food Commissioned Production Supervision Management Measures," will be released to clarify the responsibilities of both parties in commissioned food production [6]. - The administration will conduct special inspections on products like krill oil and fish oil to strengthen oversight and combat illegal activities [6]. Group 3: Company Accountability - Following the incident, the company has taken accountability measures, including the dismissal of the general manager of Sichuan Health Company and the suspension of other related management personnel [4]. - The company is cooperating with local regulatory bodies in an investigation and has submitted evidence related to the infringement by Sichuan Health [4][7]. - The company has publicly apologized and committed to pursuing legal action against those responsible for trademark infringement [7].

Core Viewpoint - The recent controversy surrounding "Tongrentang (600085) Antarctic Krill Oil" has raised significant concerns due to the product's reported phospholipid content being zero, prompting regulatory scrutiny and company actions to address the issue [1][4]. Group 1: Company Actions - Tongrentang has initiated a strict brand management special action, conducting over 520 inspections of its affiliated units/stores as of December 24 [3]. - The company has filed nearly 600 complaints against infringing products on major e-commerce platforms and has targeted over 120 unauthorized stores using the Tongrentang name [3]. - Following the incident, Tongrentang has taken steps to recall the involved products and has launched a product inquiry system on its official website to assist consumers in verifying legitimate products [2][6]. Group 2: Regulatory Response - The State Administration for Market Regulation (SAMR) plans to enhance supervision of food entrusted production practices, particularly in light of the issues revealed by the Antarctic Krill Oil incident [4]. - SAMR will soon release the "Food Entrusted Production Supervision Management Measures," which will clarify the responsibilities of both parties involved in food safety during entrusted production [4]. - A special inspection will be organized to increase oversight of products like krill oil and fish oil, aiming to combat illegal activities in the market [4].

Core Viewpoint - The Shanghai Consumer Protection Committee has exposed the "Tongrentang Antarctic Krill Oil" product for having a phospholipid content of 0, raising serious questions about the integrity of the brand and its suppliers [1] Group 1: Product Issues - The Shanghai Consumer Protection Committee published an article questioning the authenticity of the Antarctic krill oil product, highlighting concerns about potential fraud and the responsibilities of those involved [1] - Consumers are purchasing the product at a price of 50-60 yuan per bottle, while the procurement cost is only 3-4 yuan, indicating a significant markup without any actual krill oil content [1] Group 2: Company Accountability - The product in question, labeled as "Beijing Tongrentang 99% High Purity Antarctic Krill Oil," was produced by Anhui Hab Pharmaceutical Co., Ltd., with Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd. as the distributor [1] - During discussions, the distributor, Beijing Tongrentang (Sichuan), avoided addressing the issue and claimed ignorance regarding the alleged fraudulent activities, distancing themselves from the situation [1]

Core Viewpoint - The recent controversy surrounding Tong Ren Tang's Antarctic krill oil product involves allegations of ingredient falsification, leading to significant scrutiny from consumer protection authorities and potential legal actions against the involved parties [1][2]. Group 1: Product Allegations - The product labeled as "Beijing Tong Ren Tang 99% High Purity Antarctic Krill Oil" was found to have a phospholipid content of 0, contradicting its claims [1]. - Anhui Habao Pharmaceutical Co., Ltd. admitted that it did not add the claimed "Antarctic krill oil" during production, raising concerns about intentional deception [2]. Group 2: Company Responses - Beijing Tong Ren Tang (Sichuan) Health Pharmaceutical Co., Ltd. stated that they are conducting product testing and will take responsibility for consumer purchases [1]. - The Shanghai Consumer Protection Committee has urged Beijing Tong Ren Tang (Sichuan) to conduct a self-examination, inform consumers accurately, and issue an apology [2]. Group 3: Legal and Regulatory Actions - The parent company, Beijing Tong Ren Tang Health Pharmaceutical Co., Ltd., has ordered the cessation of sales of the implicated product and initiated a full investigation [2]. - Legal proceedings have been initiated against the involved companies for unauthorized use of the "Beijing Tong Ren Tang" branding, which is considered illegal [2].